257 related articles for article (PubMed ID: 33625522)
1. Evolution, structure and emerging roles of C1ORF112 in DNA replication, DNA damage responses, and cancer.
Edogbanya J; Tejada-Martinez D; Jones NJ; Jaiswal A; Bell S; Cordeiro R; van Dam S; Rigden DJ; de Magalhães JP
Cell Mol Life Sci; 2021 May; 78(9):4365-4376. PubMed ID: 33625522
[TBL] [Abstract][Full Text] [Related]
2. C1orf112 teams up with FIGNL1 to facilitate RAD51 filament disassembly and DNA interstrand cross-link repair.
Zhou Z; Yang H; Liang X; Zhou T; Zhang T; Yang Y; Wang J; Wang W
Cell Rep; 2023 Aug; 42(8):112907. PubMed ID: 37515771
[TBL] [Abstract][Full Text] [Related]
3. FLIP(C1orf112)-FIGNL1 complex regulates RAD51 chromatin association to promote viability after replication stress.
Tischler JD; Tsuchida H; Bosire R; Oda TT; Park A; Adeyemi RO
Nat Commun; 2024 Jan; 15(1):866. PubMed ID: 38286805
[TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analysis Identified
Chen J; Mai H; Chen H; Zhou B; Hou J; Jiang DK
Front Mol Biosci; 2021; 8():693651. PubMed ID: 34490347
[No Abstract] [Full Text] [Related]
5. Reconstitution of the antagonistic effect between C1orf112/FIRRM-FIGNL1 and BRCA2 on RAD51 filament stabilization.
Zhou Z; Yang H; Liang X; Zhou T; Liu Q; Wang J; Wang W
STAR Protoc; 2024 Mar; 5(1):102791. PubMed ID: 38133958
[TBL] [Abstract][Full Text] [Related]
6. High Expression of C1ORF112 Predicts a Poor Outcome: A Potential Target for the Treatment of Low-Grade Gliomas.
Zhang Z; Tan Z; Lv Q; Wang L; Yu K; Yang H; Liang H; Lu T; Ji Y; Chen J; He W; Chen Z; Chen S; Shen X
Front Genet; 2021; 12():710944. PubMed ID: 34880897
[No Abstract] [Full Text] [Related]
7. RADIF(C1orf112)-FIGNL1 Complex Regulates RAD51 Chromatin Association to Promote Viability After Replication Stress.
Tischler JD; Tsuchida H; Oda TT; Park A; Adeyemi RO
bioRxiv; 2023 Sep; ():. PubMed ID: 37808755
[TBL] [Abstract][Full Text] [Related]
8. FIRRM/C1orf112 is synthetic lethal with PICH and mediates RAD51 dynamics.
Stok C; Tsaridou S; van den Tempel N; Everts M; Wierenga E; Bakker FJ; Kok Y; Alves IT; Jae LT; Raas MWD; Huis In 't Veld PJ; de Boer HR; Bhattacharya A; Karanika E; Warner H; Chen M; van de Kooij B; Dessapt J; Ter Morsche L; Perepelkina P; Fradet-Turcotte A; Guryev V; Tromer EC; Chan KL; Fehrmann RSN; van Vugt MATM
Cell Rep; 2023 Jul; 42(7):112668. PubMed ID: 37347663
[TBL] [Abstract][Full Text] [Related]
9. FIRRM/C1orf112 mediates resolution of homologous recombination intermediates in response to DNA interstrand crosslinks.
Mazouzi A; Moser SC; Abascal F; van den Broek B; Del Castillo Velasco-Herrera M; van der Heijden I; Hekkelman M; Drenth AP; van der Burg E; Kroese LJ; Jalink K; Adams DJ; Jonkers J; Brummelkamp TR
Sci Adv; 2023 Jun; 9(22):eadf4409. PubMed ID: 37256941
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic exploitation of tumor cell defects in homologous recombination.
Powell SN; Kachnic LA
Anticancer Agents Med Chem; 2008 May; 8(4):448-60. PubMed ID: 18473729
[TBL] [Abstract][Full Text] [Related]
11. The Fanconi anaemia pathway: new players and new functions.
Ceccaldi R; Sarangi P; D'Andrea AD
Nat Rev Mol Cell Biol; 2016 Jun; 17(6):337-49. PubMed ID: 27145721
[TBL] [Abstract][Full Text] [Related]
12. Homologous recombination and cell cycle checkpoints: Rad51 in tumour progression and therapy resistance.
Henning W; Stürzbecher HW
Toxicology; 2003 Nov; 193(1-2):91-109. PubMed ID: 14599770
[TBL] [Abstract][Full Text] [Related]
13. HELQ promotes RAD51 paralogue-dependent repair to avert germ cell loss and tumorigenesis.
Adelman CA; Lolo RL; Birkbak NJ; Murina O; Matsuzaki K; Horejsi Z; Parmar K; Borel V; Skehel JM; Stamp G; D'Andrea A; Sartori AA; Swanton C; Boulton SJ
Nature; 2013 Oct; 502(7471):381-4. PubMed ID: 24005329
[TBL] [Abstract][Full Text] [Related]
14. Interplay between Fanconi anemia and homologous recombination pathways in genome integrity.
Michl J; Zimmer J; Tarsounas M
EMBO J; 2016 May; 35(9):909-23. PubMed ID: 27037238
[TBL] [Abstract][Full Text] [Related]
15. A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers.
Jirawatnotai S; Hu Y; Michowski W; Elias JE; Becks L; Bienvenu F; Zagozdzon A; Goswami T; Wang YE; Clark AB; Kunkel TA; van Harn T; Xia B; Correll M; Quackenbush J; Livingston DM; Gygi SP; Sicinski P
Nature; 2011 Jun; 474(7350):230-4. PubMed ID: 21654808
[TBL] [Abstract][Full Text] [Related]
16. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer.
Smith J; Tho LM; Xu N; Gillespie DA
Adv Cancer Res; 2010; 108():73-112. PubMed ID: 21034966
[TBL] [Abstract][Full Text] [Related]
17. Roles of BRCA1 in DNA damage repair: a link between development and cancer.
Deng CX; Wang RH
Hum Mol Genet; 2003 Apr; 12 Spec No 1():R113-23. PubMed ID: 12668603
[TBL] [Abstract][Full Text] [Related]
18. Structure and function of the RAD51B-RAD51C-RAD51D-XRCC2 tumour suppressor.
Greenhough LA; Liang CC; Belan O; Kunzelmann S; Maslen S; Rodrigo-Brenni MC; Anand R; Skehel M; Boulton SJ; West SC
Nature; 2023 Jul; 619(7970):650-657. PubMed ID: 37344587
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of BRCA2 in replication fork protection in response to hydroxyurea and DNA interstrand cross-links.
Rickman KA; Noonan RJ; Lach FP; Sridhar S; Wang AT; Abhyankar A; Huang A; Kelly M; Auerbach AD; Smogorzewska A
Genes Dev; 2020 Jun; 34(11-12):832-846. PubMed ID: 32354836
[TBL] [Abstract][Full Text] [Related]
20. RAD51 paralogs: Expanding roles in replication stress responses and repair.
Bhattacharya D; Sahoo S; Nagraj T; Dixit S; Dwivedi HK; Nagaraju G
Curr Opin Pharmacol; 2022 Dec; 67():102313. PubMed ID: 36343481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
